Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional and Pharmacological Comparison of Human, Mouse, and Rat Organic Cation Transporter 1 toward Drug and Pesticide Interaction. | Int J Mol Sci | 2020 | 32961667 | PubTator, text mining | PubMed |
| Polygenic Markers in Patients Diagnosed of Autosomal Dominant Hypercholesterolemia in Catalonia: Distribution of Weighted LDL-c-Raising SNP Scores and Refinement of Variant Selection. | Biomedicines | 2020 | 32942679 | PubTator, text mining | PubMed |
| Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. | Cancers (Basel) | 2020 | 32933095 | PubTator, text mining | PubMed |
| Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes. | Diabetes Ther | 2020 | 32930968 | PubTator, text mining | PubMed |
| Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA. | Int J Mol Sci | 2020 | 32927842 | PubTator, text mining | PubMed |
| The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition. | Int J Mol Sci | 2020 | 32927790 | PubTator, text mining | PubMed |
| Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development. | Biomedicines | 2020 | 32927779 | PubTator, text mining | PubMed |
| Polymethine Dye-Functionalized Nanoparticles for Targeting CML Stem Cells. | Mol Ther Oncolytics | 2020 | 32913887 | PubTator, text mining | PubMed |
| Interleukin-37 contributes to the pathogenesis of gout by affecting PDZ domain-containing 1 protein through the nuclear factor-kappa B pathway. | J Int Med Res | 2020 | 32910705 | PubTator, text mining | PubMed |
| Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells. | Cancers (Basel) | 2020 | 32883003 | PubTator, text mining | PubMed |
| Amantadine can induce intra-epithelial deposition in the cornea. | Am J Ophthalmol Case Rep | 2020 | 32875144 | PubTator, text mining | PubMed |
| Lack of Drug-Drug Interaction Between Cimetidine, a Renal Transporter Inhibitor, and Imeglimin, a Novel Oral Antidiabetic Drug, in Healthy Volunteers. | Eur J Drug Metab Pharmacokinet | 2020 | 32860624 | PubTator, text mining | PubMed |
| Verification of P-Glycoprotein Function at the Dermal Barrier in Diffusion Cells and Dynamic "Skin-On-A-Chip" Microfluidic Device. | Pharmaceutics | 2020 | 32854319 | PubTator, text mining | PubMed |
| Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells. | Int J Mol Sci | 2020 | 32846898 | PubTator, text mining | PubMed |
| Successful Prediction of Positron Emission Tomography-Imaged Metformin Hepatic Uptake Clearance in Humans Using the Quantitative Proteomics-Informed Relative Expression Factor Approach. | Drug Metab Dispos | 2020 | 32843330 | PubTator, text mining | PubMed |
| Investigating the GWAS-Implicated Loci for Rheumatoid Arthritis in the Pakistani Population. | Dis Markers | 2020 | 32831971 | PubTator, text mining | PubMed |
| Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters. | Biomolecules | 2020 | 32825480 | PubTator, text mining | PubMed |
| Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia. | Cells | 2020 | 32824945 | PubTator, text mining | PubMed |
| Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products. | Sci Rep | 2020 | 32820219 | PubTator, text mining | PubMed |
| A double-Flp-in method for stable overexpression of two genes. | Sci Rep | 2020 | 32820202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=59